Chongqing Lummy Pharmaceutical (300006) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.008x

Based on the latest financial reports, Chongqing Lummy Pharmaceutical (300006) has a cash flow conversion efficiency ratio of -0.008x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-14.90 Million ≈ $-2.18 Million USD) by net assets (CN¥1.85 Billion ≈ $271.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Chongqing Lummy Pharmaceutical - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Chongqing Lummy Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Chongqing Lummy Pharmaceutical balance sheet liabilities for a breakdown of total debt and financial obligations.

Chongqing Lummy Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chongqing Lummy Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Cymbria Corporation TO:CYB	0.002x
Kuros Biosciences AG SW:KURN	-0.035x
TWO HARBORS INV. DL-0001 F:2H2	0.066x
Pacira BioSciences, Inc. NASDAQ:PCRX	0.063x
Queclink Wireless Solutions Co Ltd SHE:300590	0.044x
Hana Materials Inc KQ:166090	0.049x
Far Eastern Department Stores Ltd TW:2903	0.067x
Guangdong LingXiao Pump Industry Co Ltd SHE:002884	0.076x

Annual Cash Flow Conversion Efficiency for Chongqing Lummy Pharmaceutical (2006–2024)

The table below shows the annual cash flow conversion efficiency of Chongqing Lummy Pharmaceutical from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see Chongqing Lummy Pharmaceutical stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.88 Billion ≈ $275.59 Million	CN¥185.03 Million ≈ $27.08 Million	0.098x	+155.72%
2023-12-31	CN¥2.12 Billion ≈ $310.54 Million	CN¥81.53 Million ≈ $11.93 Million	0.038x	+46.92%
2022-12-31	CN¥2.18 Billion ≈ $319.73 Million	CN¥57.13 Million ≈ $8.36 Million	0.026x	-46.58%
2021-12-31	CN¥2.21 Billion ≈ $323.70 Million	CN¥108.28 Million ≈ $15.84 Million	0.049x	-73.15%
2020-12-31	CN¥1.23 Billion ≈ $180.22 Million	CN¥224.54 Million ≈ $32.86 Million	0.182x	+30.35%
2019-12-31	CN¥1.65 Billion ≈ $241.99 Million	CN¥231.30 Million ≈ $33.85 Million	0.140x	+6.75%
2018-12-31	CN¥1.72 Billion ≈ $252.28 Million	CN¥225.89 Million ≈ $33.05 Million	0.131x	+267.72%
2017-12-31	CN¥1.72 Billion ≈ $252.11 Million	CN¥61.39 Million ≈ $8.98 Million	0.036x	-52.53%
2016-12-31	CN¥1.67 Billion ≈ $245.00 Million	CN¥125.66 Million ≈ $18.39 Million	0.075x	+599.18%
2015-12-31	CN¥1.69 Billion ≈ $247.28 Million	CN¥-25.41 Million ≈ $-3.72 Million	-0.015x	+69.04%
2014-12-31	CN¥1.02 Billion ≈ $148.81 Million	CN¥-49.38 Million ≈ $-7.23 Million	-0.049x	-173.18%
2013-12-31	CN¥1.13 Billion ≈ $164.73 Million	CN¥74.70 Million ≈ $10.93 Million	0.066x	+159.29%
2012-12-31	CN¥710.51 Million ≈ $103.97 Million	CN¥18.18 Million ≈ $2.66 Million	0.026x	+42.56%
2011-12-31	CN¥660.17 Million ≈ $96.60 Million	CN¥11.85 Million ≈ $1.73 Million	0.018x	-73.23%
2010-12-31	CN¥561.59 Million ≈ $82.18 Million	CN¥37.66 Million ≈ $5.51 Million	0.067x	-5.73%
2009-12-31	CN¥525.08 Million ≈ $76.84 Million	CN¥37.35 Million ≈ $5.47 Million	0.071x	-43.18%
2008-12-31	CN¥137.79 Million ≈ $20.16 Million	CN¥17.25 Million ≈ $2.52 Million	0.125x	-37.70%
2007-12-31	CN¥107.91 Million ≈ $15.79 Million	CN¥21.68 Million ≈ $3.17 Million	0.201x	+66.59%
2006-12-31	CN¥64.39 Million ≈ $9.42 Million	CN¥7.77 Million ≈ $1.14 Million	0.121x	--

About Chongqing Lummy Pharmaceutical

SHE:300006 China Drug Manufacturers - General

Market Cap

$987.34 Million

CN¥6.75 Billion CNY

Market Cap Rank

#9171 Global

#2465 in China

Share Price

CN¥6.39

Change (1 day)

-0.78%

52-Week Range

CN¥3.44 - CN¥6.52

All Time High

CN¥11.34